Healthcare & Life Sciences News and Articles

Google News – Clinical Trials External News

SRD-002 Gene Therapy Shows Sustained HFpEF Improvement at 12 Months - The Clinical Trial Vanguard

news.google.com · 01 Sep 2026

Google News – Clinical Trials External News

Applied Biologics Activates First Clinical Site in Phase 3 BIOxHEAL™ Trial - GlobeNewswire

news.google.com · 01 Sep 2026

Google News – Clinical Trials External News

Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy - PR Newswire

news.google.com · 01 Sep 2026

Google News – Clinical Trials External News

Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy - prnewswire.com

news.google.com · 01 Sep 2026

Google News – Clinical Trials External News

Novartis pauses trials of experimental cell therapy after three deaths - PharmaLive

news.google.com · 01 Sep 2026

Google News – Clinical Trials External News

Kazia Therapeutics Expands Paxalisib Clinical Trial into HR+/HER2- Breast Cancer, Supported by Preclinical Data Showing Strong Clinical Activity and Safety in HR+ Breast Cancer - PR Newswire

news.google.com · 01 Sep 2026

Google News – Clinical Trials External News

Novartis reports positive Phase III results for remibrutinib in RMS - Clinical Trials Arena

news.google.com · 01 Sep 2026

Google News – Clinical Trials External News

Ocugen Announces First Patient Dosed in Phase 3 Registrational Trial of OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration - Ocugen, Inc.

news.google.com · 01 Sep 2026

Google News – Clinical Trials External News

Ocugen Announces First Patient Dosed in Phase 3 Registrational Trial of OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration - Yahoo Finance

news.google.com · 01 Sep 2026

Google News – Clinical Trials External News

Ocugen Doses First Patient in OCU410 Phase 3 Trial | OCGN Stock News - Stock Titan

news.google.com · 01 Sep 2026

Google News – Clinical Trials External News

Medable and ICON Exceed Patient eConsent Adoption Goals for Women’s Health Study on Menopause - Business Wire

news.google.com · 01 Sep 2026

Google News – Clinical Trials External News

Novartis: Three deaths put CAR-T expansion into autoimmune diseases on hold - European Biotechnology Magazine

news.google.com · 01 Sep 2026

Google News – Clinical Trials External News

Novartis pauses eight CAR-T trials after three patient deaths - Новости GxP

news.google.com · 01 Sep 2026

Google News – Clinical Trials External News

Joining a clinical trial, hurdles to know about - Jefferson City News Tribune

news.google.com · 01 Sep 2026

Google News – Clinical Trials External News

Stop Writing ‘Routine Labs.’ Every Lab Line Needs Its Own Coverage Citation - The Clinical Trial Vanguard

news.google.com · 01 Sep 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

SRD-002 Gene Therapy Shows Sustained HFpEF Improvement at 12 Months - The Clinical Trial Vanguard

Applied Biologics Activates First Clinical Site in Phase 3 BIOxHEAL™ Trial - GlobeNewswire

Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy - PR Newswire

Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy - prnewswire.com

Novartis pauses trials of experimental cell therapy after three deaths - PharmaLive

Kazia Therapeutics Expands Paxalisib Clinical Trial into HR+/HER2- Breast Cancer, Supported by Preclinical Data Showing Strong Clinical Activity and Safety in HR+ Breast Cancer - PR Newswire

Novartis reports positive Phase III results for remibrutinib in RMS - Clinical Trials Arena

Ocugen Announces First Patient Dosed in Phase 3 Registrational Trial of OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration - Ocugen, Inc.

Ocugen Announces First Patient Dosed in Phase 3 Registrational Trial of OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration - Yahoo Finance

Ocugen Doses First Patient in OCU410 Phase 3 Trial | OCGN Stock News - Stock Titan

Medable and ICON Exceed Patient eConsent Adoption Goals for Women’s Health Study on Menopause - Business Wire

Novartis: Three deaths put CAR-T expansion into autoimmune diseases on hold - European Biotechnology Magazine

Novartis pauses eight CAR-T trials after three patient deaths - Новости GxP

Joining a clinical trial, hurdles to know about - Jefferson City News Tribune

Stop Writing ‘Routine Labs.’ Every Lab Line Needs Its Own Coverage Citation - The Clinical Trial Vanguard